Clin2
NCT07026643Possibly a fitNot yet recruiting

aVNT treatment for POTS pilot study

Postural Orthostatic Tachycardia Syndrome (POTS)

Part of Brain & nervous system clinical trials.

This pilot study tests a treatment called aVNT for people with POTS. It aims to see if this treatment can help with symptoms like rapid heartbeat when standing up.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You have been diagnosed with POTS and are between 18 and 80 years old.
  • You are not taking stimulants (like ADHD medication) for at least a week before the study.
  • You do not have serious heart, lung, kidney, or blood problems, or a history of stroke or cancer.
  • You are not pregnant or breastfeeding.
  • You do not have a pacemaker or a past surgery called vagotomy.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06996314Not yet recruiting
Nerve stimulation with slow breathing for POTS

This trial tests a gentle, non-invasive treatment for Postural Orthostatic Tachycardia Syndrome (POTS), a condition that causes a rapid heart rate when standing. It combines mild ear nerve stimulation with slow, paced breathing to see if it helps manage symptoms like dizziness and fatigue.

NCT07585513Not yet recruiting· Phase 2
Beta-3 therapy to help POTS symptoms

This trial tests a new medication (mirabegron) to help people with POTS (postural orthostatic tachycardia syndrome)—a condition where your heart races and you feel dizzy when standing up. The drug works by activating a specific nerve pathway to help control your heart rate and blood pressure.

NCT07163130Not yet recruiting
Tragus nerve stimulation for POTS

This study tests a non-invasive device that stimulates a nerve near your ear (called the tragus) to see if it can help manage POTS symptoms. It may be an option for people whose POTS has lasted more than 6 months and who do not have other serious health conditions.

NCT07757555Not yet recruiting· Early Phase 1
Guanfacine and cromolyn sodium for POTS

This trial tests two medications—guanfacine and cromolyn sodium—to see if they can help people with POTS who have symptoms that started after a specific trigger. It might help if you have not found relief from other treatments.

Baltimore, Maryland
NCT06936319Recruiting
Body movements for POTS symptom control

This study tests simple body movements (like squeezing your legs or squatting) to see if they help control POTS symptoms. It may offer a non-drug way to manage dizziness and fast heart rate when standing.

Innsbruck, Tyrol
NCT07019519Recruiting
Gut hormones and blood flow in POTS

This study looks at how gut hormones control blood flow after eating in people with POTS. It may help explain symptoms like dizziness and rapid heartbeat after meals.

Copenhagen

Hear when a new Postural Orthostatic Tachycardia Syndrome (POTS) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.